AN2 Therapeutics, Inc.ANTXNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank83
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-0.98
↑ 88% vs avg
Percentile
P83
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-8.00
Historical baseline
PeriodValueYoY Change
2025-0.98-22.1%
2024-0.80+89.3%
2023-7.47-109.3%
2022-3.57+73.4%
2021-13.40+36.9%
2020-21.22-148.5%
2019-8.54-